Biological markers around immediately placed titanium implant in the extraction socket of diabetic and insulin-treated rat maxilla.
10.5125/jkaoms.2012.38.4.204
- Author:
Suhyun PARK
1
;
Hyun A HEO
;
Won LEE
;
Sung Woon PYO
Author Information
1. Department of Oral and Maxillofacial Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea. spyo@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Type 1 diabetes;
Dental implant;
Insulin;
Biological markers
- MeSH:
Alloys;
Animals;
Biological Factors;
Biomarkers;
Bone Morphogenetic Proteins;
Dental Implants;
Humans;
Insulin;
Maxilla;
Molar;
Osteocalcin;
Osteogenesis;
Osteonectin;
Rats;
Streptozocin;
Titanium;
Transforming Growth Factor beta1;
Transforming Growth Factors
- From:Journal of the Korean Association of Oral and Maxillofacial Surgeons
2012;38(4):204-211
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: Dental implants installation in patients with diabetes remains controversial as altered bone healing around implants has been reported. And little is known about the biological factors involved in bone healing around implants. The present study aimed to investigate the biological markers around immediately placed implants in rats with controlled and uncontrolled diabetes. MATERIALS AND METHODS: Twenty rats (40 sites) were divided into the control, insulin-treated and diabetic groups. The rats received streptozotocin (60 mg/kg) to induce diabetes; animals in the insulin-treated group also received three units of subcutaneous slow-release insulin. Two threaded titanium alloy implant (1.2x3 mm) were placed in the extraction socket of the both maxillary first molars and allowed for healing. Bone blocks including implant were harvested at 3 days, 1, 2 and 4 weeks. The levels of bone morphogenetic protein (BMP)-4, transforming growth factor (TGF)-beta1, osteocalcin (OC) and osteonectin (ON) were measured in the peri-implant osseous samples by RT-PCR. RESULTS: The BMP-4 level increased immediately in all groups by day 3, then decreased abruptly in the control and the insulin-treated groups. However, by week 4, all groups showed mostly the same amount of BMP-4 expression. The level of TGF-beta1 also instantly increased by day 3 in the insulin-treated group. This level elevated again reaching the same values as the control group by week 4, but was not as high as the diabetic group. In addition, the expression of OC and ON in the control and insulin-treated groups was higher than that of the diabetic group at 2 weeks and 4 weeks, indicating active bone formation in these groups. CONCLUSION: The immediate placement of titanium implants in the maxilla of diabetic rat led to an unwanted bone healing response. Conclusively, the results of this study suggest that immediate implant insertion in patients with poorly controlled diabetes might be contraindicated.
